• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEMAITRE VASCULAR, INC. XENOSURE BIOLOGICAL PATCH; MESH, SURGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEMAITRE VASCULAR, INC. XENOSURE BIOLOGICAL PATCH; MESH, SURGICAL Back to Search Results
Catalog Number UNKNOWN
Device Problem Occlusion Within Device (1423)
Patient Problems Wound Dehiscence (1154); Stroke/CVA (1770); Death (1802); Pseudoaneurysm (2605)
Event Type  Death  
Manufacturer Narrative
Patient is known to be diabetic/hypertensive and had recently quit smoking.We have not received the patch for evaluation from the hospital.Hence, we could conclusively determine the relationship of the patch to the reported adverse event.This report was uncovered during the sales rep.Interaction with the physician at roughly 6 months after this issue occured.Therefore, the information provided was from the doctor's recollection not immediately following this event.Lemaitre was made aware of this event (by the doctor) on 8/29/2017.Since the specific lot number was not known, a comprehensive review of all the lot history records sold to the customer was conducted.There were no discrepancies noted that would result to this issue.We also have not received any other complaints from other customers for these lots related to similar issue.We did present this case to our medical director who has extensive experience with bovine patches.Upon review of the case information, he believes that the xensure patch was not a contributor to the issue and was the result of the infection caused by external sources or carriers most likely at the time of surgery and did not originate with the patch material.The investigation is ongoing.
 
Event Description
Patient experienced dehiscence, pseudoaneurysm and stroke after 2 weeks of implantation of xenosure patch.Patient was deceased at 1 month post operation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XENOSURE BIOLOGICAL PATCH
Type of Device
MESH, SURGICAL
Manufacturer (Section D)
LEMAITRE VASCULAR, INC.
63 second ave
burlington MA 01803
Manufacturer (Section G)
LEMAITRE VASCULAR, INC.
63 second ave
burlington MA 01803
Manufacturer Contact
pragya thikey
63 second ave
burlington, MA 01803
7812212266
MDR Report Key6902574
MDR Text Key87721355
Report Number1220948-2017-00057
Device Sequence Number0
Product Code DXZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K040835
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 09/29/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/28/2017
Is this an Adverse Event Report? Yes
Device Operator Physician
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received08/29/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-